- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01916005
Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis
The diagnosis of prosthetic valve endocarditis (PVE) remains challenging. In PVE cases, initial echocardiography is normal or inconclusive in almost 30% of cases, leading to a decreased diagnostic accuracy for the modified Duke criteria.
Aims: The investigators sought to determine the value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for diagnosing PVE.
Methods: In two referral French centers (Timone Hospial, Marseille and Georges Pompidou European Hospital, Paris), the investigators plan to include consecutive patients suspected of having PVE. All of the patients will be subjected to clinical, microbiological, and echocardiographic evaluation. Cardiac PET/CT will be performed at admission and the data analysis will be based on visual interpretation and quantitative measurement of FDG uptake (SUVmax). The final diagnosis will be defined according to the clinical and/or pathological modified Duke criteria determined during a 3-month follow-up (gold standard).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hôpitaux de Marseille
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- unexplained persistent or recurrent fever >38°C;
- and/or unexplained increased serum C-reactive protein (CRP) level >10 mg/L; and/or positive blood cultures, independent of the echocardiographic analysis results;
- and/or positive serological testing for Coxiella burnetii, Bartonella spp., Mycoplasma pneumoniae, Legionella pneumophila, Aspergillus spp., or Tropheryma whipplei;
- and/or a mass or a new partial prosthetic valve dehiscence observed using echocardiography.
Exclusion Criteria:
- pregnancy,
- an inability to lie flat,
- a need for urgent cardiac surgery,
- hemodynamic instability,
- cardiac surgery <1 month ago,
- and a blood glucose level >1.8 g/L. Patients with a poor PET/CT image quality
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: endocarditis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the diagnosis of prosthetic valve infective endocarditis
Time Frame: 39months
|
18F-fluorodeoxyglucose positron emission tomography
|
39months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the reproducibility of the technique,
Time Frame: 39 months
|
the other diagnostic parameters of PET/CT (specificity and predictive values)
|
39 months
|
|
the comparison of the sensitivity of PET/CT with that of echocardiography,
Time Frame: 39 MONTHS
|
the other diagnostic parameters of PET/CT (specificity and predictive values)
|
39 MONTHS
|
|
the rate of detection of embolic events,
Time Frame: 39 MONTHS
|
the other diagnostic parameters of PET/CT (specificity and predictive values)
|
39 MONTHS
|
|
the prognostic value of the technique (death/valve surgery)
Time Frame: 39 MONTHS
|
the other diagnostic parameters of PET/CT (specificity and predictive values)
|
39 MONTHS
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-A00056-39
- 2013-01 (Other Identifier: AP HM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.